April BNF/BNFc Newsletter

New additions include benzathine benzylpenicillin for treatment of susceptible infections, siponimod for multiple sclerosis & plerixafor for lymphoma or solid malignant tumours; as well as latest MHRA advice for Emerade, Lemtrada, Nexplanon, Picato & modafinil.

British National Formulary